Where Will Your Case Be Filed: Likelihood of Multidistrict Litigation (MDL) In Testosterone Therapy Lawsuits

April 17th, 2014 | Drug injury

A key component to successfully resolving claims against medical device or pharmaceutical companies is venue. Venue is the Court where your case is filed. Venue depends on a variety of different factors including, but not limited to, where the injury occurred, where the Plaintiff (the injured person) lives, or where the Defendant (Pharmaceutical company) is… Read More

FDA Approves New “Low T” Treatment, Despite Heart Attack Risks

March 12th, 2014 | Drug injury

All medications available to patients in the United States must undergo a rigorous testing and approval process to ensure they’re safe to use; however, medications are sometimes approved that are later determined to be harmful to patients’ health. The Ohio Drug Injury Lawyers with Nurenberg, Paris, Heller & McCarthy explain such medications include those that… Read More

Study Shows “Low T” Treatments May Increase Risk of Heart Attack and Stroke

March 3rd, 2014 | Drug injury

Getting older can be difficult for some men, considering the loss of body and bone mass, sex drive, and energy associated with aging. Science has proven many of these symptoms can be caused by lower levels of testosterone in the body. Researchers have shown that supplementing a man’s testosterone levels can reduce the significance of… Read More